Literature DB >> 5764023

Metabolic fate of tritiated busulfan in man.

H Vodopick, H E Hamilton, H L Jackson, C T Peng, R F Sheets.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5764023

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  7 in total

Review 1.  Mass balance studies, with a focus on anticancer drugs.

Authors:  Jan H Beumer; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 2.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  Prediction of Intravenous Busulfan Clearance by Endogenous Plasma Biomarkers Using Global Pharmacometabolomics.

Authors:  Yvonne S Lin; Savannah J Kerr; Timothy Randolph; Laura M Shireman; Tauri Senn; Jeannine S McCune
Journal:  Metabolomics       Date:  2016-09-15       Impact factor: 4.290

4.  Pharmacogenetics of intravenous and oral busulfan in hematopoietic cell transplant recipients.

Authors:  Nissa Abbasi; Barbara Vadnais; Jennifer A Knutson; David K Blough; Edward J Kelly; Paul V O'Donnell; H Joachim Deeg; Matthew A Pawlikowski; Rodney J-Y Ho; Jeannine S McCune
Journal:  J Clin Pharmacol       Date:  2010-12-06       Impact factor: 3.126

Review 5.  The role of busulfan in bone marrow transplantation.

Authors:  M Hassan
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

6.  Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation.

Authors:  L B Grochow; R J Jones; R B Brundrett; H G Braine; T L Chen; R Saral; G W Santos; O M Colvin
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Hepsulfam distribution in blood, plasma and cerebrospinal fluid of baboons.

Authors:  M V Marshall; K D Carey; D D Von Hoff; J G Kuhn
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.